Day One Biopharmaceuticals (DAWN) Other Gross PP&E Adjustments: 2022-2025
Historic Other Gross PP&E Adjustments for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Sep 2025 value amounting to -$8.2 million.
- Day One Biopharmaceuticals' Other Gross PP&E Adjustments fell 50.80% to -$8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.5 million, marking a year-over-year decrease of 53.44%. This contributed to the annual value of -$6.2 million for FY2024, which is 20.54% down from last year.
- According to the latest figures from Q3 2025, Day One Biopharmaceuticals' Other Gross PP&E Adjustments is -$8.2 million, which was down 26.48% from -$6.5 million recorded in Q2 2025.
- Over the past 5 years, Day One Biopharmaceuticals' Other Gross PP&E Adjustments peaked at -$1.2 million during Q1 2022, and registered a low of -$8.2 million during Q3 2025.
- For the 3-year period, Day One Biopharmaceuticals' Other Gross PP&E Adjustments averaged around -$5.1 million, with its median value being -$5.1 million (2023).
- The largest annual percentage gain for Day One Biopharmaceuticals' Other Gross PP&E Adjustments in the last 5 years was 16.14% (2023), contrasted with its biggest fall of 215.46% (2023).
- Over the past 4 years, Day One Biopharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$2.8 million in 2022, then crashed by 82.72% to -$5.1 million in 2023, then declined by 20.54% to -$6.2 million in 2024, then crashed by 50.80% to -$8.2 million in 2025.
- Its last three reported values are -$8.2 million in Q3 2025, -$6.5 million for Q2 2025, and -$7.5 million during Q1 2025.